T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$2.48B |
| 2 |
Kenvue
KVUE
|
+$1.5B |
| 3 |
Halliburton
HAL
|
+$1.12B |
| 4 |
Boeing
BA
|
+$950M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$920M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.64B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.66B |
| 4 |
Johnson & Johnson
JNJ
|
+$1.56B |
| 5 |
Amazon
AMZN
|
+$1.17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.76% |
| 2 | Healthcare | 16.83% |
| 3 | Financials | 10.91% |
| 4 | Consumer Discretionary | 10.77% |
| 5 | Communication Services | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VZIO
2676
DELISTED
VIZIO Holding Corp.
VZIO
| $93K | ﹤0.01% |
17,121
+1,502
| +10% | +$9.64K |
|
2677
Omeros
OMER
$1.24B
| $92K | ﹤0.01% |
31,228
+1,278
| +4% | +$5.13K |
|
2678
Codexis
CDXS
$180M
| $91K | ﹤0.01% |
47,856
+2,203
| +5% | +$5.15K |
|
|
TERN
2679
DELISTED
Terns Pharmaceuticals
TERN
| $90K | ﹤0.01% |
17,786
+800
| +5% | +$5.08K |
|
|
SYRS
2680
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $90K | ﹤0.01% |
22,550
| – | – |
|
|
TWKS
2681
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
| $88K | ﹤0.01% |
21,325
+2,566
| +14% | +$14.6K |
|
|
BFX
2682
DELISTED
BowFlex Inc.
BFX
| $88K | ﹤0.01% |
103,300
| – | – |
|
2683
Quantum-Si Incorporated
QSI
$191M
| $87K | ﹤0.01% |
52,045
+4,664
| +10% | +$11.2K |
|
2684
Definitive Healthcare
DH
$72.5M
| $86K | ﹤0.01% |
+10,672
| New | +$107K |
|
|
WOW
2685
DELISTED
WideOpenWest
WOW
| $86K | ﹤0.01% |
11,232
+262
| +2% | +$2.08K |
|
2686
Coherus Oncology
CHRS
$181M
| $83K | ﹤0.01% |
22,127
-16,659
| -43% | -$76.9K |
|
2687
Frontier Group Holdings
ULCC
$1.55B
| $83K | ﹤0.01% |
16,975
-3,528,287
| -100% | -$26.4M |
|
2688
Atara Biotherapeutics
ATRA
$77.1M
| $82K | ﹤0.01% |
2,200
-865
| -28% | -$38.5K |
|
|
CTLP
2689
DELISTED
Cantaloupe
CTLP
| $82K | ﹤0.01% |
13,084
+1,422
| +12% | +$10.4K |
|
2690
Custom Truck One Source
CTOS
$2.45B
| $82K | ﹤0.01% |
13,170
+1,069
| +9% | +$7.07K |
|
|
ZOM
2691
DELISTED
Zomedica Corp.
ZOM
| $82K | ﹤0.01% |
485,400
+153,400
| +46% | +$29.8K |
|
|
AMRN
2692
Amarin Corp
AMRN
$297M
| $81K | ﹤0.01% |
4,387
| – | – |
|
2693
GoodRx Holdings
GDRX
$1.22B
| $81K | ﹤0.01% |
14,300
-4,700
| -25% | -$31.3K |
|
2694
Butterfly Network
BFLY
$2.54B
| $80K | ﹤0.01% |
67,589
+2,310
| +4% | +$4.47K |
|
|
GAN
2695
DELISTED
GAN Ltd
GAN
| $80K | ﹤0.01% |
68,600
| – | – |
|
|
TIO
2696
DELISTED
Tingo Group, Inc. Common Stock
TIO
| $80K | ﹤0.01% |
77,362
-29,800
| -28% | -$37.6K |
|
|
VIA
2697
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $79K | ﹤0.01% |
10,880
| – | – |
|
2698
Caribou Biosciences
CRBU
$167M
| $78K | ﹤0.01% |
16,198
+5,652
| +54% | +$35.1K |
|
2699
Ardagh Metal Packaging
AMBP
$3.21B
| $77K | ﹤0.01% |
24,547
+3,094
| +14% | +$10.9K |
|
|
FARM
2700
DELISTED
Farmer Brothers
FARM
| $77K | ﹤0.01% |
29,600
+12,000
| +68% | +$31.4K |
|
Similar funds
T. Rowe Price Associates's Q3 2023 Portfolio in Review
As of Q3 2023, T. Rowe Price Associates held 2,959 positions worth $682B, down 4.9% from $718B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.7%. T. Rowe Price Associates opened 69 new positions and exited 71, leaving the 2,959-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2023 buy was Maplebear: 6,435,942 shares worth $191M.
- T. Rowe Price Associates added most to SLB Ltd in Q3 2023, an estimated $2.48B increase.
- T. Rowe Price Associates's biggest Q3 2023 reduction was Microsoft, cutting an estimated $2.64B.
- T. Rowe Price Associates fully exited Life Storage, Inc. in Q3 2023, selling an estimated $285M.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $682B portfolio in Q3 2023.
- T. Rowe Price Associates opened 69 new positions and closed 71 in Q3 2023.
- T. Rowe Price Associates's portfolio value fell 4.9% quarter-over-quarter to $682B.
Based on T. Rowe Price Associates's 13F filing for Q3 2023, filed 14 Nov 2023.